Harris Alex H S, Bowe Thomas, Kamal Robin N, Sears Erika D, Hawn Mary, Eisenberg Dan, Finlay Andrea K, Hagedorn Hildi J, Mudumbai Seshadri
Center for Innovation to Implementation, VA Palo Alto Healthcare System, Palo Alto, USA.
Stanford -Surgical Policy Improvement Research and Education Center, Department of Surgery, Stanford University School of Medicine, Palo Alto, USA.
Perioper Med (Lond). 2022 Sep 13;11(1):33. doi: 10.1186/s13741-022-00265-0.
Clinical practice guidelines discourage routine preoperative screening tests for patients undergoing low-risk procedures. This study sought to determine the frequency and costs of potentially low-value preoperative screening tests in Veterans Health Administration (VA) patients undergoing low-risk procedures.
Using the VA Corporate Data Warehouse, we identified Operative Stress Score class 1 procedures ("very minor") performed without general anesthesia in VA during fiscal year 2019 and calculated the overall national and facility-level rates and costs of nine common tests received in the 30 preoperative days. Patient factors associated with receiving at least one screening test, and the number of tests received, were examined.
Eighty-six thousand three hundred twenty-seven of 178,775 low-risk procedures (49.3%) were preceded by 321,917 potentially low-value screening tests representing $11,505,170 using Medicare average costs. Complete blood count was the most common (33.2% of procedures), followed by basic metabolic profile (32.0%), urinalysis (26.3%), electrocardiography (18.9%), and pulmonary function test (12.4%). Older age, female sex, Black race, and having more comorbidities were associated with higher odds of low-value testing. Transthoracic echocardiogram occurred prior to only 4.5% of the procedures but accounted for 47.8% of the total costs ($5,499,860). In 129 VA facilities, the facility-level proportion of procedures preceded by at least one test ranged from 0 to 81.2% and facility-level costs ranged from $0 to $388,476.
Routine preoperative screening tests for very low-risk procedures are common and costly in some VA facilities. These results highlight a potential target to improve quality and value by reducing unnecessary care. Measures of low-value perioperative care could be integrated into VA's extensive quality monitoring and improvement infrastructure.
临床实践指南不鼓励对接受低风险手术的患者进行常规术前筛查测试。本研究旨在确定退伍军人健康管理局(VA)中接受低风险手术的患者进行潜在低价值术前筛查测试的频率和成本。
利用VA企业数据仓库,我们确定了2019财年在VA进行的无需全身麻醉的1级手术应激评分手术(“非常小”),并计算了术前30天内接受的九种常见测试的全国总体和机构层面的发生率及成本。研究了与接受至少一项筛查测试相关的患者因素以及接受测试的数量。
在178,775例低风险手术中,有86,327例(49.3%)在术前进行了321,917次潜在低价值筛查测试,按照医疗保险平均成本计算,这些测试花费了11,505,170美元。全血细胞计数是最常见的(占手术的33.2%),其次是基本代谢指标(32.0%)、尿液分析(26.3%)、心电图(18.9%)和肺功能测试(12.4%)。年龄较大、女性、黑人种族以及合并症较多与低价值测试的较高几率相关。经胸超声心动图仅在4.5%的手术前进行,但占总成本的47.8%(5,499,860美元)。在129个VA机构中,至少进行一项测试的手术在机构层面的比例从0到81.2%不等,机构层面的成本从0到388,476美元不等。
在一些VA机构中,对极低风险手术进行常规术前筛查测试很常见且成本高昂。这些结果突出了通过减少不必要的护理来提高质量和价值的一个潜在目标。低价值围手术期护理措施可纳入VA广泛的质量监测和改进基础设施中。